Dexterous Endoscopes awarded CHF 130k EPFL Ignition and Innogrant funding
Dexterous Endoscopes secured CHF 130k in EPFL Startup Launchpad funding, combining the Ignition and Innogrant programs. The support will expand the team, advance a clinically viable prototype, and enable the first cadaver trials.

Dexterous Endoscopes has received two competitive funding instruments from EPFL Startup Launchpad: an Ignition Grant of CHF 30,000 and an Innogrant of CHF 100,000.
The Ignition Grant helps early-stage EPFL spin-offs validate their concepts, while the Innogrant provides seed funding to accelerate the transition of promising research into startups with market potential.
This funding will be used to grow the team with complementary medical device expertise, advance towards a minimally clinically viable product, and conduct the first preclinical cadaver trials to validate the clinical hypotheses behind our variable stiffness endoscopes.
These steps mark important progress toward making ENT surgeries faster, less invasive, and safer for patients.